What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic?

+ See all authors and affiliations

Science Translational Medicine  14 Nov 2012:
Vol. 4, Issue 160, pp. 160cm14
DOI: 10.1126/scitranslmed.3004915

You are currently viewing the abstract.

View Full Text


Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.

View Full Text

Related Content